Taipei Exchange - Delayed Quote TWD

Advagene Biopharma Co., Ltd. (6709.TWO)

Compare
20.20
0.00
(0.00%)
As of 11:59:51 AM GMT+8. Market Open.
Currency in TWD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
93,336.00
93,336.00
119,810.00
94,426.00
75,793.00
Operating Income
-93,336.00
-93,336.00
-119,810.00
-94,426.00
-75,793.00
Net Non Operating Interest Income Expense
981.00
981.00
1,231.00
1,400.00
1,591.00
Pretax Income
-92,110.00
-92,110.00
-118,377.00
-92,686.00
-70,162.00
Net Income Common Stockholders
-92,110.00
-92,110.00
-118,377.00
-92,686.00
-70,162.00
Diluted NI Available to Com Stockholders
-92,110.00
-92,110.00
-118,377.00
-92,686.00
-70,162.00
Basic EPS
-1.83
--
-2.40
-1.88
-1.57
Diluted EPS
-1.83
--
-2.40
-1.88
-1.57
Basic Average Shares
50,333.33
--
49,323.75
49,176.99
44,725.06
Diluted Average Shares
53,380.00
--
49,323.75
49,176.99
44,725.06
Total Expenses
93,336.00
93,336.00
119,810.00
94,426.00
75,793.00
Net Income from Continuing & Discontinued Operation
-92,110.00
-92,110.00
-118,377.00
-92,686.00
-70,162.00
Normalized Income
-92,110.00
-92,110.00
-118,377.00
-92,686.00
-70,162.00
Interest Income
1,017.00
1,017.00
1,312.00
1,527.00
1,698.00
Interest Expense
36.00
36.00
81.00
127.00
107.00
Net Interest Income
981.00
981.00
1,231.00
1,400.00
1,591.00
EBIT
-92,074.00
-92,074.00
-118,296.00
-92,559.00
-70,055.00
EBITDA
-80,072.00
-80,072.00
-106,694.00
-84,834.00
-62,168.00
Reconciled Depreciation
12,002.00
12,002.00
11,602.00
7,725.00
7,887.00
Net Income from Continuing Operation Net Minority Interest
-92,110.00
-92,110.00
-118,377.00
-92,686.00
-70,162.00
Normalized EBITDA
-80,072.00
-80,072.00
-106,694.00
-84,834.00
-62,168.00
12/31/2020 - 11/29/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers